摘要
随着长非编码RNA (lncRNA)的作用与种类被不断地研究与阐明,lncRNA与肿瘤耐药的关系越来越受到关注.研究发现lncRNA通过改变DNA修复与细胞周期、药物外排系统、药物代谢、细胞凋亡和上皮间质转化等过程参与肿瘤耐药.lncRNA有望成为新的生物学标志物,为肿瘤的诊断、治疗和预后评估提供新的途径.
With the continuous research and elucidation of the role and species of long non-coding RNAs (lncRNAs),the relationship between lncRNAs and cancer resistance has been paid more and more attention by researchers.Studies find that lncRNAs are involved in tumor drug resistance by altering DNA repair and cell cycle,drug delivery system,drug metabolism,cell apoptosis and epithelial interstitial transformation.lncRNAs are expected to be a new biological marker,which provids a new way to diagnose,treat and evaluate the prognosis of cancer.
作者
周童
贾颜鸿
毕也
张泽兵
Zhou Tong;Jia Yanhong;Bi Ye;Zhang Zebing.(Department of Pathology, Hospital of Stomatology, Jilin University, Changchun 130021, China)
出处
《国际肿瘤学杂志》
CAS
2018年第4期223-225,共3页
Journal of International Oncology
基金
吉林省自然科学基金(20150101174JC)
关键词
RNA
肿瘤
抗药性
RNA
Neoplasms
Drug resistance